search
Back to results

Musculoskeletal Changes After Physiotherapeutic Intervention in Podiatric Subjects (BIONEDIAN)

Primary Purpose

Prevention of Diabetic Foot

Status
Unknown status
Phase
Not Applicable
Locations
Czechia
Study Type
Interventional
Intervention
Physical intervention by exercise
Sponsored by
Mgr. Eliška Vrátná
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Prevention of Diabetic Foot focused on measuring diabetic foot, biomechanics, quality of life, prevention

Eligibility Criteria

30 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Type 2 diabetes mellitus
  • sensoric neuropathy (mild - based on VPV 15-30 V or EMG results, severe - based on VPT above 50 V or EMG results)
  • diabetic foot with healed diabetic foot ulcers, inactive Charcot foot

Exclusion Criteria:

  • impossibility to exercise
  • amaurosis
  • non-compliance
  • critical limb ischemia
  • active ulcer, surgical wound
  • active Charcot foot
  • active carcinoma
  • recent stroke (last 8 weeks)
  • recent myocardial infarction (last 8 weeks)
  • recent PTA, PCI, bypass (last 8 weeks)
  • myopathy
  • rheumatoid arthritis
  • cox-, gonartrosis of 3rd -4th grade.

Sites / Locations

  • Institute for Clinical and Experimental MedicineRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Active Comparator

Experimental

Experimental

Arm Label

DF patient active

DF patient control

Diabetic patient with mild neuropathy

Diabetic patient with severe neuropathy

Arm Description

Patients with Type 2 diabetes mellitus and diabetic foot, whose have healed diabetic foot ulcers

Patients with Type 2 diabetes mellitus and diabetic foot, whose have healed diabetic foot ulcers

Patients with Type 2 diabetes mellitus with mild form of peripheral sensory neuropathy

Patients with Type 2 diabetes mellitus with severe form of peripheral sensory neuropathy

Outcomes

Primary Outcome Measures

Biomechanics- plantar pressures
plantar pressures will be evaluated by pedobarograph (in Newtons)
Biomechanics- biomechanics of the ankle
biomechanics of the ankle will be assessed by goniometry in angles
Biomechanics- changes of foot joint angles
changes of foot joint agles will be evaluated by measurement of X-Rays bones angles - calcaneal pitch, talar-1st metatarsal angle and lateral Talocalcaneal angle
Fitness - physical activity
The amount of physical activity will be assessed by IPAQ questioners
Fitness - muscle strength
Muscle strength will be measured by dynamometry in Newtons
Fitness - senior fitness
fitness will be assessed by seniorfittest containing 2 minutes step test (steps/2 min) and test of sitting (sits/30 seconds)

Secondary Outcome Measures

ulceration/reulceration
detection of the incidence of ulceration/reulceration
Psychosocial changes - quality of life
Quality of life will be evaluated by WHO-QoL Bref test (4 domains - high values mean bettr findings
Psychosocial changes - depression
Depression status will be asessed by Geriatric Depression Scale (GDS) scale - minimum 0, maximum 30 points (higher then 9 points- mild form of depression, higher then 20 - severe depression
Psychosocial changes - stress readaptation
Adaptation to stress will be detected by Stress Readaption Scale (0-400 points) - points higher then 150 - higher risk of worse stress readaptation and therefore higher risk of somatisation
Metabolism - glucose control
Investigators will be loked for metabolic changes in diabetes control (HbA1c in mmol/mol, glycemia in mmol/l)
Metabolism - lipid profile
The authors will control lipid profiles (Total-, HDL-, LDL-cholesterol in umol/l)
Metabolism - myokines
Patients will be checked for changes in selected cytokines nad myokines (IL-4,6,7,8,15 in pg/ml, myostatin in pg/ml, irisin in ng/ml, FGF-21 in pg/ml)

Full Information

First Posted
December 15, 2019
Last Updated
February 3, 2020
Sponsor
Mgr. Eliška Vrátná
Collaborators
Vladimíra Fejfarová, MD, PhD, prof. Ing. Václav Bunc, CSc
search

1. Study Identification

Unique Protocol Identification Number
NCT04257409
Brief Title
Musculoskeletal Changes After Physiotherapeutic Intervention in Podiatric Subjects
Acronym
BIONEDIAN
Official Title
Musculoskeletal Changes Induced by Physiotherapeutic Intervention, and Their Impact on the Induction of Diabetic Foot Syndrome and Psychosocial Status in Type 2 Diabetes Mellitus
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Unknown status
Study Start Date
January 1, 2019 (Actual)
Primary Completion Date
March 30, 2020 (Anticipated)
Study Completion Date
January 1, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Mgr. Eliška Vrátná
Collaborators
Vladimíra Fejfarová, MD, PhD, prof. Ing. Václav Bunc, CSc

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The recurrence of diabetic foot ulcers (DFU) is a key problem in podiatric care. It is very often given by biomechanical abnormalities frequently present in those patients. The aim of our randomized controlled study is to find possible changes as of plantar pressures as of biomechanics of the ankle and small joints in patients with type 2 diabetes mellitus with different degrees of neuropathy. During this project, investigators will examine the possible impact of 12-week lasting intervention program on the distribution of plantar pressures, joint mobility and muscle strength of lower limbs. The incidence of ulcerations / reulcerations and changes of psychosocial characteristics will be evaluated during the study period. Approximately 60 patients with Type 2 diabetes mellitus will be included into the study. These patients will be randomized into 3 study groups - patients with type 2 DM with mild form of peripheral sensory neuropathy (20 subjects), patient with severe peripheral neuropathy (20 subjects) and those with diabetic foot syndrome, without active lesion (20 subjects). All patients will undergo 12 week lasting active intervention program consisting of recommendations by a physiotherapist focusing on the improvement of physical fitness, muscle strength and foot joint improvement. Control group will be consisted of 20 patients with healed diabetic foot. The outcomes of this project will try to objectively verify in the randomized controlled trial the impact of exercise on lower limb biomechanics, mobility, self-sufficiency, quality of life in patients with type 2 diabetes mellitus at risk or already developed diabetic foot syndrome.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prevention of Diabetic Foot
Keywords
diabetic foot, biomechanics, quality of life, prevention

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
60 patients with Type 2 diabetes mellitus. These patients will be randomized into 3 study groups - patients with type 2 DM with mild form of peripheral sensory neuropathy (20 subjects), patient with severe peripheral neuropathy (20 subjects) and those with diabetic foot syndrome, without active lesion (20 subjects). All patients will undergo 12 week lasting active intervention program consisting of recommendations by a physiotherapist focusing on the improvement of physical fitness, muscle strength and foot joint improvement. Control group will be consisted of 20 patients with healed diabetic foot.
Masking
Participant
Masking Description
randomization of diabetic patients with healed diabetic foot according the randomization scheme
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
DF patient active
Arm Type
Experimental
Arm Description
Patients with Type 2 diabetes mellitus and diabetic foot, whose have healed diabetic foot ulcers
Arm Title
DF patient control
Arm Type
Active Comparator
Arm Description
Patients with Type 2 diabetes mellitus and diabetic foot, whose have healed diabetic foot ulcers
Arm Title
Diabetic patient with mild neuropathy
Arm Type
Experimental
Arm Description
Patients with Type 2 diabetes mellitus with mild form of peripheral sensory neuropathy
Arm Title
Diabetic patient with severe neuropathy
Arm Type
Experimental
Arm Description
Patients with Type 2 diabetes mellitus with severe form of peripheral sensory neuropathy
Intervention Type
Other
Intervention Name(s)
Physical intervention by exercise
Intervention Description
12 week lasting exercise intervention
Primary Outcome Measure Information:
Title
Biomechanics- plantar pressures
Description
plantar pressures will be evaluated by pedobarograph (in Newtons)
Time Frame
changes after 12 weeks, 24 weeks
Title
Biomechanics- biomechanics of the ankle
Description
biomechanics of the ankle will be assessed by goniometry in angles
Time Frame
changes after 12 weeks, 24 weeks
Title
Biomechanics- changes of foot joint angles
Description
changes of foot joint agles will be evaluated by measurement of X-Rays bones angles - calcaneal pitch, talar-1st metatarsal angle and lateral Talocalcaneal angle
Time Frame
changes after 12 weeks, 24 weeks
Title
Fitness - physical activity
Description
The amount of physical activity will be assessed by IPAQ questioners
Time Frame
changes after 12 weeks, 24 weeks
Title
Fitness - muscle strength
Description
Muscle strength will be measured by dynamometry in Newtons
Time Frame
changes after 12 weeks, 24 weeks
Title
Fitness - senior fitness
Description
fitness will be assessed by seniorfittest containing 2 minutes step test (steps/2 min) and test of sitting (sits/30 seconds)
Time Frame
changes after 12 weeks, 24 weeks
Secondary Outcome Measure Information:
Title
ulceration/reulceration
Description
detection of the incidence of ulceration/reulceration
Time Frame
changes after 12 weeks, 24 weeks
Title
Psychosocial changes - quality of life
Description
Quality of life will be evaluated by WHO-QoL Bref test (4 domains - high values mean bettr findings
Time Frame
changes after 12 weeks, 24 weeks
Title
Psychosocial changes - depression
Description
Depression status will be asessed by Geriatric Depression Scale (GDS) scale - minimum 0, maximum 30 points (higher then 9 points- mild form of depression, higher then 20 - severe depression
Time Frame
changes after 12 weeks, 24 weeks
Title
Psychosocial changes - stress readaptation
Description
Adaptation to stress will be detected by Stress Readaption Scale (0-400 points) - points higher then 150 - higher risk of worse stress readaptation and therefore higher risk of somatisation
Time Frame
changes after 12 weeks, 24 weeks
Title
Metabolism - glucose control
Description
Investigators will be loked for metabolic changes in diabetes control (HbA1c in mmol/mol, glycemia in mmol/l)
Time Frame
changes after 12 weeks, 24 weeks
Title
Metabolism - lipid profile
Description
The authors will control lipid profiles (Total-, HDL-, LDL-cholesterol in umol/l)
Time Frame
changes after 12 weeks, 24 weeks
Title
Metabolism - myokines
Description
Patients will be checked for changes in selected cytokines nad myokines (IL-4,6,7,8,15 in pg/ml, myostatin in pg/ml, irisin in ng/ml, FGF-21 in pg/ml)
Time Frame
changes after 12 weeks, 24 weeks

10. Eligibility

Sex
All
Gender Based
Yes
Gender Eligibility Description
30-75 years
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Type 2 diabetes mellitus sensoric neuropathy (mild - based on VPV 15-30 V or EMG results, severe - based on VPT above 50 V or EMG results) diabetic foot with healed diabetic foot ulcers, inactive Charcot foot Exclusion Criteria: impossibility to exercise amaurosis non-compliance critical limb ischemia active ulcer, surgical wound active Charcot foot active carcinoma recent stroke (last 8 weeks) recent myocardial infarction (last 8 weeks) recent PTA, PCI, bypass (last 8 weeks) myopathy rheumatoid arthritis cox-, gonartrosis of 3rd -4th grade.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Eliška Vrátná, Mgr.
Phone
+420774549214
Email
vratnae@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Vladimíra Fejfarová, MD, PhD
Phone
+420603877381
Email
vlfe@medicon.cz
Facility Information:
Facility Name
Institute for Clinical and Experimental Medicine
City
Prague
ZIP/Postal Code
14200
Country
Czechia
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Eliška Vrátná, Mgr.
Phone
+420774549214
Email
vratnae@gmail.com
First Name & Middle Initial & Last Name & Degree
Vladimíra Fejfarová, MD, PhD
Phone
+420603877381
Email
vlfe@medicon.cz
First Name & Middle Initial & Last Name & Degree
Jitka Hazdrová, MD

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Possible to look at the data in documentation site

Learn more about this trial

Musculoskeletal Changes After Physiotherapeutic Intervention in Podiatric Subjects

We'll reach out to this number within 24 hrs